CardioDefender

CardioDefender™

A Major Advance in the Early Diagnosis of Arrhythmias

CardioDefender:  A major advance in real-time ECG monitoring; assists physicians in the early diagnosis and treatment of arrhythmia

The Everist Genomics CardioDefender1 system is a major advance in ECG monitoring and overcomes the limitations associated with legacy ECG systems.

 

CardioDefender is the world’s only FDA and CE Mark approved smartphone based, fully mobile ECG system which provides physicians and patients with the quality of hospital-based ECG systems; real-time, beat-by-beat, quantitative heart monitoring and reporting but utilizing the convenience of mobile, wireless technology.

 

The breakthrough performance capabilities of CardioDefender include:

  1. Approved by US and European regulatory authorities; CardioDefender is FDA approved and CE Mark.  Use of the CardioDefender system is also reimbursed in the USA and Europe.
  2. Fully mobile system; CardioDefender is the world’s first ECG system which delivers hospital based quality ECG and arrhythmia analysis by integrating unique software, algorithms and data compression capabilities which enable a smartphone to perform as a mobile ECG
  3. Real-time, heart-rhythm monitoring
  4. Beat-by-beat analysis of heart rhythm (as opposed to sampling some heart beats or part of a heart beat)
  5. Long term monitoring capability; CardioDefender can perform up to 3 months of real-time, beat-by-beat quantitative patient monitoring and analysis
  6. Quantitative analysis and reporting; CardioDefender is a fully automated, quantitative ECG monitoring and arrhythmia event reporting system
  7. Comprehensive range of heart rhythm monitoring algorithms to enable automated detection and reporting of medically important arrhythmias to physicians and monitoring centers
  8. Abnormal heart rhythms reported directly to physicians mobile phone or computer; innovative and patent protected software and data compression technology means CardioDefender can report real-time results to a physician’s smartphone, tablets, laptop and desk top computer (in addition to a cardiac monitoring center)
  9. Access to full, detailed ECG data captured during the monitoring period, including post heart monitoring data processing for additional measurements
  10. Real-time reporting of symptomatic and asymptomatic arrhythmias; CardioDefender has the ability to capture and report both symptomatic and asymptomatic arrhythmias

CardioDefender also has the most comprehensive range of algorithms (currently 24 in total) for the automated detection of medically important arrhythmias.  These automatically detected arrhythmias can be reported to a cardiac monitoring center and to the patient’s physician.

CardioDefender Automated Arrhythmia Detection Capabilities
Type of Automated Arrhythmia Detection Capabilities

  Heart Rate
Arrhythmias		 Ventricular
Arrhythmias		 Supraventricular Arrhythmias Customizable Alerts
and Capability
 
  1. Asystole
  2. Pause
  3. Bradycardia
  4. Missed beat
 
  1. Single beat
  2. Single beat “R on T” type
  3. Couplet
  4. Triplet
  5. Ventricular tachycardia
  6. Bigeminy
  7. Trigeminy
  8. Idioventricular rhythm
  9. Accelerated idioventricular rhythm
  1. Single beat
  2. Couplet
  3. Triplet
  4. Supraventriucular run
  5. Atrial fibrillation / atrial flutter
  6. Bigeminy
  7. Trigeminy
  1. Operator selected events
  2. Reported / marked by patient events
  3. Electrodes disconnected
  4. Signal synchronization

In summary, no other portable ECG system matches the performance capabilities of CardioDefender, (refer to the comparative capability analysis in the exhibit below).

 

CardioDefender Capabilities Versus Legacy ECG System Performance


Required ECG Capability		 CardioDefender Mobile Cardiac Outpatient Telemetry (MCOT) Automatic Event Recorder Manual ECG Event Recorder Holter
Ability to record ECG data Yes Yes Yes Yes Yes
Ability to report symptomatic events Yes Yes Yes Yes Yes
Annotations for beat-by-beat heart rhythm analysis including post heart monitoring data processing and data mining Yes No No No Yes
Access to full, detailed ECG data captured during the monitoring period, including post heart monitoring data processing for additional measurements Yes No No No Yes
Quantitative representation of atrial fibrillation burden, real time, beat-beat, quantitative analysis Yes No. Limited to 30 second snapshots per 10 minutes No No Yes
Quantitative representation of other arrhythmias with option to correlate results Yes No No No Yes
Fully mobile, real-time, beat-by-beat, fully automated, quantitative ECG monitoring and arrhythmia event reporting Yes No No No No
Comprehensive range of heart rhythm monitoring algorithms (currently 24 in total) for the automated detection and reporting of medically important arrhythmias Yes No No No No
Ability to perform up to 3 months of real-time, beat-by-beat quantitative patient monitoring and analysis Yes No No No No
Remote access by physicians to real-time patient heart rhythm monitoring events and results as part of an ongoing patient study from smartphone, laptop, or desk top computer Yes No No No No
Trends and histograms to represent important arrhythmias Yes No. Limited to atrial fibrillation only No No No
Quantitative “rate and rhythm” analysis of atrial fibrillation Yes No No No No
Quantitative analysis of patient symptoms versus occurring arrhythmias Yes No No No No

 

 

  1. Marketed in the United States and EU as PocketECG